| 2025 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 7,8 M € | -98.0% | 387,1 M € | +3.3% | 374,9 M € | +36.0% | 275,6 M € | +4.5% | 263,7 M € | +10.2% | 239,2 M € | +12.1% | 213,4 M € | -0.0% | 213,4 M € | +7.1% | 199,3 M € | -5.4% | 210,7 M € | +16.8% | 180,3 M € | +4.0% | 173,4 M € | +282.9% | 45,3 M € | — | — | — | ||||
| EBITDA | -1,3 M € | -140.2% | 3,2 M € | -31.2% | 4,7 M € | -56.6% | 10,7 M € | +50.8% | 7,1 M € | -22.5% | 9,2 M € | +42.3% | 6,5 M € | -26.4% | 8,8 M € | +156.6% | 3,4 M € | -73.8% | 13,0 M € | +13.8% | 11,5 M € | +50.8% | 7,6 M € | +700.7% | 948,6 k € | +6542.6% | -14,7 k € | -600.1% | -2,1 k € | +60.5% | -5,3 k € | |
| Operating profit | -1,0 M € | -140.4% | 2,5 M € | -34.6% | 3,8 M € | -62.0% | 10,0 M € | +52.1% | 6,5 M € | -29.6% | 9,3 M € | +129.8% | 4,0 M € | -54.5% | 8,9 M € | +217.1% | 2,8 M € | -77.4% | 12,4 M € | +9.9% | 11,3 M € | +51.6% | 7,4 M € | +684.5% | 948,3 k € | +6540.7% | -14,7 k € | -600.1% | -2,1 k € | +60.5% | -5,3 k € | |
| Profit/loss | 796,3 k € | -30.2% | 1,1 M € | -61.1% | 2,9 M € | -53.9% | 6,4 M € | +56.5% | 4,1 M € | -37.3% | 6,5 M € | +125560.7% | 5,2 k € | -99.9% | 4,6 M € | +53.8% | 3,0 M € | -55.5% | 6,7 M € | -22.3% | 8,6 M € | +72.2% | 5,0 M € | +347.4% | 1,1 M € | +99.0% | 563,0 k € | +9240.2% | 6,0 k € | +22.0% | 4,9 k € | |
| Equity | 95,4 M € | +13.2% | 84,3 M € | +1.4% | 83,1 M € | +3.7% | 80,2 M € | +8.6% | 73,8 M € | +5.8% | 69,8 M € | +10.2% | 63,3 M € | -25.8% | 85,3 M € | +5.7% | 80,7 M € | +3.8% | 77,7 M € | +9.4% | 71,0 M € | +13.8% | 62,4 M € | +8.7% | 57,4 M € | +3.2% | 55,6 M € | +4307.2% | 1,3 M € | +0.5% | 1,3 M € | |
| Total assets | 100,5 M € | -29.7% | 143,1 M € | -9.3% | 157,8 M € | +19.0% | 132,6 M € | +17.4% | 112,9 M € | -6.4% | 120,6 M € | -9.8% | 133,7 M € | +10.7% | 120,8 M € | -1.3% | 122,4 M € | -8.2% | 133,3 M € | +16.9% | 114,0 M € | -6.6% | 122,1 M € | +40.2% | 87,1 M € | +56.8% | 55,6 M € | +4306.9% | 1,3 M € | +0.2% | 1,3 M € | |
| Cash | 132,7 k € | -21.5% | 169,1 k € | -18.3% | 207,0 k € | +262.0% | 57,2 k € | +28.7% | 44,4 k € | +87.7% | 23,7 k € | -41.9% | 40,7 k € | -70.9% | 139,9 k € | -32.4% | 207,1 k € | +1882481.8% | 11,0 € | -99.5% | 2,4 k € | -93.2% | 35,3 k € | -92.9% | 494,8 k € | — | — | — | ||||
| Debts | 4,3 M € | -92.4% | 56,2 M € | -22.7% | 72,7 M € | +43.5% | 50,7 M € | +34.2% | 37,8 M € | -23.7% | 49,5 M € | -28.5% | 69,3 M € | +98.5% | 34,9 M € | -15.1% | 41,1 M € | -25.6% | 55,2 M € | +29.8% | 42,6 M € | -28.1% | 59,2 M € | +99.2% | 29,7 M € | +1035495.9% | 2,9 k € | +1814.7% | 150,0 € | -96.3% | 4,0 k € | |
| Staff | 17,8 | 25,4 | 24,3 | 30,5 | 33,9 | 35,6 | 36,4 | 37,1 | 38,7 | 25 | 19,3 | 12,7 | 4,7 | — | — | — | ||||||||||||||||
Public limited company · Gent · incorporated on 05/11/2008 · 17,8 ETP
Public limited company profitable and well capitalised. Cash position declining (-21.5%).
Solid counterparty for a standard engagement.
OMEGA PHARMA INTERNATIONAL is a Public limited company incorporated in 2008. Its main activity is: Commerce de gros de produits pharmaceutiques et médicaux. Its registered office is in Gent. It employs on average 17,8 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette